BiotechTube
Home/Adlai Nortye/Peter Zhang
PZ

Peter Zhang

Chief Scientific Officer

Adlai Nortye

Therapeutic Areas

Oncology

Adlai Nortye Pipeline

DrugIndicationPhase
AN2025 (Buparlisib)Recurrent or metastatic Head and Neck Squamous Cell CarcinomaPhase 3
AN0025 (Eganelisib)Locally Advanced Rectal CancerPhase 1b/2
AN4005Advanced or Metastatic Solid TumorsPhase 1
AN8025Advanced Solid TumorsPhase 1
AN1025Advanced Solid TumorsPhase 1
AN9025Not SpecifiedPreclinical
AN3025Not SpecifiedPreclinical
AN2025SNot SpecifiedPreclinical

Leadership Team at Adlai Nortye

LB
Lars Birgerson
President & Chief Executive Officer
KR
Kefei Ren
Chief Operating Officer
MM
Mao Mao
Chief Medical Officer
CG
Caroline Germa
Executive Vice President, Global Development
ML
Mingjun Liu
Chief Financial Officer
View full Adlai Nortye profile